Venous thromboembolism (VTE), comprising deep vein thrombosis (DVT), and pulmonary
embolism (PE), is becoming increasingly recognized as a cause of morbidity and mortality in …

Pulmonary embolism is the third most common cause of death from cardiovascular disease
after heart attack and stroke. Sequelae occurring after venous thromboembolism include …

Background A systemic inflammatory response is observed in coronavirus disease 2019
(COVID-19). Elevated serum levels of C-reactive protein (CRP), a marker of systemic …

C-reactive protein (CRP) is a member of the highly conserved pentraxin superfamily of
proteins and is often used in clinical practice as a marker of infection and inflammation …

Vascular disease is a progressive inflammatory condition fuelled by an unhealthy lifestyle of
physical inactivity, cholesterol-rich diet, and smoking. Together with endogenous factors …

Background: Patients with acute coronary syndrome are at risk for peripheral artery disease
(PAD) events and venous thromboembolism (VTE). PCSK9 (proprotein convertase …

Although inflammation-induced thrombosis is a well-known entity, its pathogenesis remains
complicated. There are complex interactions between inflammation and hemostasis …

Pulmonary embolism is the third most common cardiovascular disease after myocardial
infarction and stroke. The death rate from pulmonary embolism exceeds the death rate from …

Clinical observations and accumulating laboratory evidence support a complex interplay
between coagulation, inflammation, innate immunity and fibrinolysis in venous …

Background—A simple and effective heart failure (HF) risk score would facilitate the primary
prevention and early diagnosis of HF in general practice. We examined the external validity …